Takeda Pharmaceutical Non-GAAP EPS of ¥308.00, revenue of ¥2407B; upgrades FY 2026 outlook
Read original article on Breaking News on Seeking Alpha →Related news
-
Shell Non-GAAP EPADS of $3.83 beats by $0.16, revenue of $92.85B misses by $8.01B; gives Q4 outlook
-
Bessent: Future Fed rate hikes not necessarily a mistake
-
ING directs €1.9B to shareholder returns via buyback and cash payment
-
Regional Management declares $0.30 dividend
-
Broadstone Net Lease declares $0.2925 dividend
-
Core Laboratories declares $0.01 dividend
-
Houlihan Lokey declares $0.70 dividend
-
Airbus SE GAAP EPS of €4.54, revenue of €50.65B; reaffirms FY 2026 outlook
Business
Corporate
France